Pharmaceuticals
Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Not intended for US-, Canada- and UK-based media DARMSTADT, Germany and NEW YORK, March 13, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced an update from the Phase III JAVELIN Head and Neck 100 study evaluating avelumab in addition to chemoradiotherapy (CRT) versus stand...
2020-03-13 20:00
8129
Embracing the Age of Innovation with Chinese Pharmaceutical Practitioners, CPhI China Returns with its 20th Edition in 2020
SHANGHAI, March 13, 2020 /PRNewswire/ -- China's pharmaceutical industry is rapidly switching from the "quantity increase" to the "quality improvement", developing from a "generic drug power" to an "innovative drug power". CPhI China, a participant and witness of this historic stage, has forged a...
2020-03-13 09:00
3542
International Psoriasis Council Statement On The Coronavirus (COVID-19) Outbreak
ST. LOUIS, March 13, 2020 /PRNewswire/ -- The rapid spread of the coronavirus (COVID-19) is a serious public health concern. It remains unknown to what extent the coronavirus impacts psoriasis and the treatment of psoriasis. The International Psoriasis Council (IPC) advises physicians to be aler...
2020-03-13 03:59
2289
INOVIO Receives New $5 Million Grant to Accelerate Scale Up of Smart Delivery Device for Its COVID-19 Vaccine
PLYMOUTH MEETING, Pennsylvania, March 12, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new$5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the ...
2020-03-12 20:00
3348
Bactiguard Launches Product That Protects Against Coronavirus
STOCKHOLM, March 12, 2020 /PRNewswire/ -- Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds. Previous experience shows that the proven effect can be transferred to new variants ...
2020-03-12 15:49
2822
Progress of the Small Sample Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
HANGZHOU, China and SHAOXING, China, March 10, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the progress of the small sample clinical trial of Ganovo® and Ritonavir combination therapy on Novel Coronavirus Pneumonia. One of the treatment groups in this study is the ...
2020-03-10 17:30
4031
Pebble Labs and Virbac Announce the Signing of a Comprehensive Commercial Agreement for Aquaculture Disease Prevention
Companies will work to bring RNA-based technologies to global large-scale aquaculture, and focus on a solution for White Spot Syndrome Virus, a disease that can cause 50% crop loss LOS ALAMOS, New Mexico and CARROS, France, March 10, 2020 /PRNewswire/ -- Pebble LabsUSA Inc., a biotechnology comp...
2020-03-09 23:41
3525
Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications
SUZHOU, China and ROCKVILLE, MD., March 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that two clinical studies of...
2020-03-09 20:00
2065
NAGASE/Nagase Medicals and Osaka University Launch Joint Research Program
TOKYO, March 5, 2020 /PRNewswire/ -- NAGASE & CO., LTD. ("NAGASE") and Osaka University ("OU") have launched DDS Products Joint Development Research Chair, a course dedicated to research in the development of production methods of liposomal formulations and lipid-based nanoparticulate formulation...
2020-03-05 14:00
1198
Zuellig Pharma acquires Alliance Pharma (Cambodge) in Cambodia to strengthen Indochina presence
SINGAPORE, March 5, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare
services provider inAsia, has announced that it has acquired a controlling
stake in Alliance Pharma (Cambodge), a leading healthcare distributor ofCambodia
.
2020-03-05 08:15
6079
New Disinfection Spray From Lipidor and Aurena Laboratories
STOCKHOLM, March 4, 2020 /PRNewswire/ -- In connection with the ongoing outbreak of Covid-19, caused by the new coronavirus, demand for disinfectants has snowballed and many products have suffered from supply shortages. Lipidor (Nasdaq First North: LIPI) has previously developed a spray for hand ...
2020-03-04 15:20
1802
DoctorOnCall Partners Merchantrade Money to Offer Convenient Digital Health Service to App Users
KUALA LUMPUR, Malaysia, March 4, 2020 /PRNewswire/ -- Recently, DoctorOnCall has signed a Partnership agreement with Merchantrade Asia Sdn Bhd (Merchantrade). This partnership will allow users of the Merchantrade Money application to access online consultations with accredited doctors and e-...
2020-03-04 13:30
5482
Merck's New LANEXO™ System to Improve Scientists' Productivity in the Lab
- First-to-market digital laboratory informatics solution with RFID labels for rapid access to reagent data - Improves inventory management; facilitates regulatory compliance; minimizes reagent waste - Reduces time on repetitive, error-prone tasks DARMSTADT, Germany, March 4, 2020 /PRNewswi...
2020-03-04 03:00
3712
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
Human Trials Planned for April; One Million Doses Expected by Year End PLYMOUTH MEETING, Pennsylvania, March 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infe...
2020-03-03 21:00
3822
CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation with Techorizon
VERONA, Italy, March 3, 2020 /PRNewswire/ -- CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients. InFebruary 2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced TheClinical digital...
2020-03-03 20:00
2831
Bactiguard Completes Acquisition of Vigilenz
STOCKHOLM, March 2, 2020 /PRNewswire/ -- Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on4 February 2020. All conditions precedent have been fulfilled and the first part...
2020-03-02 22:06
9069
ConvaTec sharpens focus on Asia Pacific and emerging markets
SINGAPORE, March 2, 2020 /PRNewswire/ -- ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the forefront of its new operating model by establishing a fully integrated business unit called the Global Emerging Markets (GEM), according to...
2020-03-02 18:06
9879
Yuyu Pharma, Laying the foundation for establishing a global-level compliance system with one of Korea's top law firms
SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...
2020-03-02 17:00
1381
ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, disease progression ...
2020-03-02 15:02
5296
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced
HONG KONG, March 2, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the clinical research of Favipiravir tablet, which was co-developed by the Group and t...
2020-03-02 14:15
7779
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 321 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 293 media titles]
2025-01-13 10:44
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 283 media titles]
2025-01-14 21:00
VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20322
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6480
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
5610
Boqii Announces ADS Ratio Change
2025-01-11 05:30
4945
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
4926
